Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKelso Grp Hldg Regulatory News (KLSO)

Share Price Information for Kelso Grp Hldg (KLSO)

Share Price is delayed by 15 minutes
Get Live Data
3.30    0.00 (0.00%)
Bid:
2.80
Ask:
3.30
Spread: 0.50 (17.857%)
Market Cap: £15.31m
KLSO Live PriceLast checked at - London Stock Exchange

Intraday Kelso Grp Hldg Share Chart

Comment on THG Plc

10 Oct 2024 17:00

RNS Number : 7686H
Kelso Group Holdings PLC
10 October 2024
 

10 October 2024

 

Kelso Group Holdings Plc

("Kelso" or the "Company") 

Comment on THG Plc

 

Kelso, the main market listed acquisition vehicle, notes the announcement from THG Plc ('THG') at 4.52pm today regarding the early advancement of its plans to demerge Ingenuity and the associated placing. THG is Kelso's second largest shareholding.

Kelso believes in Ingenuity's model and its long term future and that the demerger will be highly beneficial for Ingenuity, as well as for THG Beauty and MyProtein as the remaining parts of THG. Kelso believes that the value of the two remaining businesses are each worth more than the current market capitalisation of THG.

Kelso is also supportive of the placing announced today and pleased with the board's speed of execution and decisive action. Kelso intends to participate in the placing.

 

For further information please contact:

Kelso Group Holdings plc

+44 (0) 75 4033 3933

John Goold, Chief Executive Officer

Mark Kirkland, Chief Financial Officer

Jamie Brooke, Chief Investment Officer

Zeus (Broker)

+44 (0) 20 3829 5000

Nick Cowles, Ed Beddows, John Moran (Investment Banking)

Ben Robertson (Corporate Broking)

Camarco

+44 (0) 20 3757 4980

Billy Clegg, Tom Huddart

 

About Kelso

Kelso was established in November 2022 to identify, engage and unlock trapped value in the UK stock market. Kelso's strategy is to invest in situations where it believes there is an anomaly between the intrinsic value and prospects of a company and its stock market valuation. Kelso will, in particular, look for situations where it believes the sum of the parts of a business is greater than the current value. The Kelso team is led by an experienced and well-invested Board and management team with a track record of identifying and creating value in the UK small and mid-cap public markets. There may be instances where Kelso itself could be used as a vehicle by an undervalued company to spin off a subsidiary into its own listing. The board of Kelso owns 20.5% of the equity having invested in each of the last three fundraising rounds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCMMBATMTABBRI
12
Date   Source Headline
5th Jun 20267:00 amRNSPortfolio update
28th May 20267:00 amRNSNotice of AGM
22nd May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSResult of Placing and Subscription
13th May 20267:00 amRNSProposed Placing and Subscription
30th Apr 20267:00 amRNSFY25 Results
27th Apr 20267:00 amRNSNew investment in Filtronic plc
22nd Apr 20265:33 pmRNSHolding(s) in Company
22nd Apr 20265:32 pmRNSHolding(s) in Company
22nd Apr 20265:32 pmRNSHolding(s) in Company
27th Feb 20265:36 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSUpdate on Investment: TheWorks.co.uk Plc
20th Feb 20267:00 amRNS-RYellowstone Advisory Presentation
17th Feb 20267:00 amRNSNew investment in CVS Group plc
22nd Jan 20267:00 amRNSUpdate on Investment in NCC Group plc
15th Jan 20269:55 amRNSNotification of Major Holdings
6th Jan 20267:00 amRNSNew investment in Saga plc
17th Dec 20257:00 amRNSResult of Placing and Subscription
16th Dec 20257:00 amRNSUpsizing of Placing and Subscription
15th Dec 20254:35 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim results for six months ended 30 June 2025
25th Jun 20254:17 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Update
30th May 20259:06 amRNSNotice of AGM
23rd May 20257:15 amRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSPurchase of Shares & PDMR Shareholding
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSFY24 Results
27th Nov 20247:00 amBUSHolding(s) in Company
7th Nov 20247:00 amRNSOliver Hemsley Appointment & Selkirk IPO Update
17th Oct 20247:00 amRNSUpdate on Kelso Investments
10th Oct 20245:00 pmRNSComment on THG Plc
1st Oct 20248:00 amRNSListing Rule 9.6.14(1) announcement
30th Sep 20247:00 amRNSInterim results for six months ended 30 June 2024
16th Aug 20247:00 amRNSUpdate on Investment in NCC Group Plc
2nd Aug 20247:00 amRNSUpdate on Investment in NCC
7th Jun 20247:00 amRNSNotification of Major Holdings
4th Jun 20247:00 amRNSNotification of Major Holdings
30th May 20244:00 pmRNSResult of AGM
30th May 20247:00 amRNSAGM Trading Update
21st May 20247:00 amRNSVoting intentions at THG AGM
8th May 202411:44 amRNSConfirmation of Accounts and Notice of AGM
8th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:02 amRNSFurther investment in NCC Group Plc
30th Apr 20247:00 amRNSFull-year results for 12 months ended 31 Dec 2023
4th Apr 20248:00 amRNSNotice of Results
14th Mar 20247:00 amRNSNotification of Major Holdings
14th Feb 20247:01 amRNSNED Appointments to The Works
14th Feb 20247:00 amRNSNotification of Major Holdings
30th Jan 20247:00 amRNSNotification of Major Holdings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.